Eli Lilly and Company

Associate Vice President - Assistant General Counsel, Business Development Transactions

Chester, Maryland, United States

Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, Legal ServicesIndustries

Position Overview

  • Location Type:
  • Job Type: Full time
  • Salary:

Lilly is a global healthcare leader headquartered in Indianapolis, Indiana, dedicated to uniting caring with discovery to improve lives worldwide. Our employees are committed to discovering and delivering life-changing medicines, enhancing disease understanding and management, and contributing to our communities through philanthropy and volunteerism. We are seeking an experienced, collaborative, leadership-focused, and detail-oriented Associate Vice President to join our Business Development Transactions organization within the Legal department. This role involves leading and managing a wide range of corporate transactions and cross-functional project teams, collaborating with senior business stakeholders to provide exceptional service and counsel in bringing medicines to patients. The position reports to the Vice-President and Head of Transactions.

Responsibilities

  • Serve as an experienced attorney on the Transactions team, focusing on business transactions, mergers and acquisitions, research and technology collaborations, and innovative partnerships that advance business development and drive innovation at Lilly.
  • Work in a dynamic environment with broad responsibility and influence, demonstrating versatility and a team-oriented approach.
  • Stay abreast of industry trends and effectively draft, review, and negotiate complex agreements related to the acquisition and licensing of pharmaceutical intellectual property and other assets, as well as collaboration agreements.
  • Drive large negotiation teams across various functions, including business development, finance, accounting, tax, ethics and compliance, human resources, and Lilly’s research & development labs, throughout the transactional lifecycle.
  • Provide strategic and legal advice for complex business transactions, including designing transaction structures, leading contract negotiation teams, consolidating input from across the Lilly enterprise, and partnering with Lilly’s senior management for efficient execution.

Requirements

  • Basic Requirements:

    • J.D. from an ABA-accredited law school.
    • Admission to the bar in at least one of the fifty states.
    • Eligibility for admission to the bar in Indiana under Indiana Admissions Rules.
    • Minimum of 10 years of legal experience in drafting, review, and negotiation of corporate transactions, including pharmaceutical intellectual property licensing, mergers and acquisitions, collaborations, technology platforms, innovative transactions, partnerships, and equity or venture capital-related financings. This experience should be from a law firm or in-house at a pharmaceutical or biotechnology company, or a combination thereof.
  • Additional Skills/Preferences:

    • Demonstrated ability to independently manage material corporate transactions from initiation to execution with limited oversight.
    • Proven ability to originate creative and innovative solutions to transactional issues.
    • Excellent verbal and written communication skills, with the ability to influence others productively.
    • Experience managing outside counsel relationships, including new engagements, new matters, and ongoing billing.

Skills

Corporate Transactions
Mergers and Acquisitions
Research and Technology Collaborations
Partnership Negotiation
Legal Drafting
Legal Review
Negotiation
Leadership
Cross-functional Collaboration

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI